(Total Views: 613)
Posted On: 02/27/2021 10:53:15 PM
Post# of 145247
https://www.businesswire.com/news/home/20201106005112/en/
Humanigen Announces Positive Interim Phase 3 Data of Lenzilumab™ in Patients Hospitalized with COVID-19
Nov 06, 2020
Humanigen Announces Positive Interim Phase 3 Data of Lenzilumab™ in Patients Hospitalized with COVID-19
Nov 06, 2020
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)